159 related articles for article (PubMed ID: 15880044)
1. The granzyme B and interferon-gamma enzyme-linked immunospot assay as alternatives for cytotoxic T-lymphocyte precursor frequency after renal transplantation.
van Besouw NM; Zuijderwijk JM; de Kuiper P; Ijzermans JN; Weimar W; van der Mast BJ
Transplantation; 2005 May; 79(9):1062-6. PubMed ID: 15880044
[TBL] [Abstract][Full Text] [Related]
2. Granzyme B ELISPOT assay determines the cytotoxic T lymphocyte precursor frequency after HLA-identical living-related kidney transplantation.
Gerrits JH; van de Wetering J; Ijzermans JN; Weimar W; van Besouw NM
Transplant Proc; 2005 Mar; 37(2):752-4. PubMed ID: 15848521
[TBL] [Abstract][Full Text] [Related]
3. Independence of granzyme B secretion and interferon- gamma production during acute simian immunodeficiency virus infection.
Calarota SA; Otero M; Robinson TM; Dai A; Lewis MG; Boyer JD; Weiner DB
J Infect Dis; 2006 May; 193(10):1441-50. PubMed ID: 16619193
[TBL] [Abstract][Full Text] [Related]
4. Application of the granzyme B ELISPOT assay for monitoring cancer vaccine trials.
Shafer-Weaver K; Rosenberg S; Strobl S; Gregory Alvord W; Baseler M; Malyguine A
J Immunother; 2006; 29(3):328-35. PubMed ID: 16699376
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin inhibitor withdrawal in stable kidney transplant patients decreases the donor-specific cytotoxic T lymphocyte precursor frequency.
van der Mast BJ; Rischen-Vos J; de Kuiper P; Vaessen LM; van Besouw NM; Weimar W
Transplantation; 2005 Nov; 80(9):1220-5. PubMed ID: 16314789
[TBL] [Abstract][Full Text] [Related]
6. After discontinuation of calcineurin inhibitors, tapering of mycophenolate mofetil further impairs donor-directed cytotoxicity.
van Besouw NM; van de Wetering J; van der Mast BJ; de Kuiper R; Baan CC; Weimar W
Clin Transplant; 2008; 22(2):129-35. PubMed ID: 18339130
[TBL] [Abstract][Full Text] [Related]
7. New approaches for monitoring CTL activity in clinical trials.
Malyguine A; Strobl S; Zaritskaya L; Baseler M; Shafer-Weaver K
Adv Exp Med Biol; 2007; 601():273-84. PubMed ID: 17713015
[TBL] [Abstract][Full Text] [Related]
8. The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity.
Shafer-Weaver K; Sayers T; Strobl S; Derby E; Ulderich T; Baseler M; Malyguine A
J Transl Med; 2003 Dec; 1(1):14. PubMed ID: 14697097
[TBL] [Abstract][Full Text] [Related]
9. Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity.
Rininsland FH; Helms T; Asaad RJ; Boehm BO; Tary-Lehmann M
J Immunol Methods; 2000 Jun; 240(1-2):143-55. PubMed ID: 10854609
[TBL] [Abstract][Full Text] [Related]
10. Non-HLA T-cell reactivity during the first year after HLA-identical living-related kidney transplantation.
Gerrits JH; van de Wetering J; Drabbels JJ; IJzermans JN; Claas FH; Weimar W; van Besouw NM
Clin Transplant; 2009; 23(5):740-7. PubMed ID: 19563488
[TBL] [Abstract][Full Text] [Related]
11. Evaluating antigen-specific cytotoxic T lymphocyte responses by a novel mouse granzyme B ELISPOT assay.
Ewen CL; Rong J; Kokaji AI; Bleackley RC; Kane KP
J Immunol Methods; 2006 Jan; 308(1-2):156-66. PubMed ID: 16375915
[TBL] [Abstract][Full Text] [Related]
12. CTL ELISPOT assay.
Ranieri E; Popescu I; Gigante M
Methods Mol Biol; 2014; 1186():75-86. PubMed ID: 25149304
[TBL] [Abstract][Full Text] [Related]
13. Deficient TNF-alpha and IFN-gamma production correlates with nondetectable donor-specific cytotoxicity after clinical kidney transplantation.
van Besouw NM; de Kuiper R; van der Mast BJ; van de Wetering J; Baan CC; Weimar W
Transplantation; 2009 May; 87(10):1451-4. PubMed ID: 19461480
[TBL] [Abstract][Full Text] [Related]
14. Pre- and post-transplant monitoring of granzyme B enzyme-linked immunosorbent spot assay in pediatric liver recipients.
Truong DQ; Cornet A; Wieërs G; Robert A; Reding R; Latinne D
Transpl Immunol; 2008 Jul; 19(3-4):215-9. PubMed ID: 18602007
[TBL] [Abstract][Full Text] [Related]
15. [Detection of antigen-epitope-specific cytotoxic T lymphocytes in patients with hepatitis B virus infection by enzyme linked immunospot assay].
Zhang HP; Yan HP; Zhang YH; Feng X; Zhao Y; Liao HY; Liu YM; Chen Y; Tan YF; Liu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Aug; 43(8):690-4. PubMed ID: 20021848
[TBL] [Abstract][Full Text] [Related]
16. Donor-reactive cytokine profiles after HLA-identical living-related kidney transplantation.
Gerrits JH; van de Wetering J; Drabbels JJ; Claas FH; Weimar W; van Besouw NM
Nephrol Dial Transplant; 2008 Jun; 23(6):2016-23. PubMed ID: 18156655
[TBL] [Abstract][Full Text] [Related]
17. Porcine antigen-specific IFN-γ ELISpot as a potentially valuable tool for monitoring cellular immune responses in pig-to-non-human primate islet xenotransplantation.
Kim HJ; Yoon IH; Min BH; Kim YH; Shin JS; Kim JM; Kim JS; Nam HY; Lee WW; Park CG
Xenotransplantation; 2016 Jul; 23(4):310-9. PubMed ID: 27464486
[TBL] [Abstract][Full Text] [Related]
18. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.
van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W
Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590
[TBL] [Abstract][Full Text] [Related]
19. The frequency of interferon-gproducing cells reflects alloreactivity against minor histocompatibility antigens.
van Besouw NM; Vaessen LM; Zuijderwijk JM; van Vliet M; IJzermans JN; van Der Meide PH; Weimar W
Transplantation; 2003 Apr; 75(8):1400-4. PubMed ID: 12717238
[TBL] [Abstract][Full Text] [Related]
20. Pretransplant donor-specific interferon-gamma ELISPOT assay predicts acute rejection episodes in renal transplant recipients.
Kim SH; Oh EJ; Kim MJ; Park YJ; Han K; Yang HJ; Kim JY; Choi BS; Yang CW; Kim YS; Bang BK
Transplant Proc; 2007 Dec; 39(10):3057-60. PubMed ID: 18089321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
